Skip to main content
. 2017 Aug 3;38(10):1021–1028. doi: 10.1093/carcin/bgx078

Figure 3.

Figure 3.

Receiver operating characteristics of Michikawa-HCC risk score and DNA methylation marker among subjects with Michikawa-HCC risk score ≥8. Michikawa-HCC risk score (AUC = 58%, 95% CI = 52–65%), DNA methylation (AUC = 61%, 95% CI = 55–68%), TBX2 methylation and HBV/HCV (AUC = 64%, 95% CI = 58–71%) and Michikawa-HCC risk score, and DNA methylation (AUC = 65%, 95% CI = 58–71%).